Who would have thought last December that we would be having these conversations???? Sam Lee had 500,000,000 reasons to help Paul take the Bio Harp to market. Now he is going to have to settle for much less. It will actually benefit the shareholders and XMDC if he ends up with less shares. Hopefully in a few weeks or so we can get back to what the Bio Harp is all about. We all want to make a lot of money in the stock but I am really interested in what this device can do. It has the potential to reveal itself as a key component in the future of diagnostic medicine. And for the stock, one day in the future if you see the device in your doctors office you will only smile and remember one of the greatest success stories that ever happened in penny land. Best of luck to Paul, Xtend Medical and all the shareholders when we go to mediation. As a great video game once said its time to finish the fight.
News 
Market Data 
Discover 
AI
